APA (7th ed.) Citation

J, G., M, L., L, Z., Q, Z., N, W., Y, W., . . . C, G. (2026). Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma, 67(3), 685. https://doi.org/10.1080/10428194.2025.2605516

Chicago Style (17th ed.) Citation

J, Guo, et al. "Clinical Outcomes of Modified Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for T-cell Acute Lymphoblastic Leukemia/lymphoma." Leukemia & Lymphoma 67, no. 3 (2026): 685. https://doi.org/10.1080/10428194.2025.2605516.

MLA (9th ed.) Citation

J, Guo, et al. "Clinical Outcomes of Modified Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for T-cell Acute Lymphoblastic Leukemia/lymphoma." Leukemia & Lymphoma, vol. 67, no. 3, 2026, p. 685, https://doi.org/10.1080/10428194.2025.2605516.